InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

- Current share price for FRE : $0.031

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Cleansing Notice 19 Dec 2023 12:08PM $0.050 $0.031 fallen by 38%
$9 Application for quotation of securities - FRE 19 Dec 2023 12:08PM $0.050 $0.031 fallen by 38%
$9 Nasodine COVID-19 Patent Granted in South Africa 29 Nov 2023 8:39AM $0.058 $0.031 fallen by 46.55%
$9 Results of Annual General Meeting 17 Nov 2023 3:26PM $0.078 $0.031 fallen by 60.26%
$9 Firebrick Investor Update 15 Nov 2023 8:47AM $0.037 $0.031 fallen by 16.22%
$9 Firebrick Receives $1.81m R&D Tax Incentive 31 Oct 2023 9:06AM $0.037 $0.031 fallen by 16.22%
$9 September 2023 Quarterly Activity Report & Appendix 4C 27 Oct 2023 8:49AM $0.038 $0.031 fallen by 18.42%
$9 Letter to Shareholders & Notice of AGM & Proxy Form 17 Oct 2023 8:24AM $0.040 $0.031 fallen by 22.50%
$9 Update on Nasodine Trial and Forward Plans 3 Oct 2023 9:11AM $0.050 $0.031 fallen by 38%
$9 Notice of AGM and Closing Date for Director Nominations 18 Sep 2023 11:45AM $0.062 $0.031 fallen by 49.59%
$9 Phase 3 Common Cold Trial Results 13 Sep 2023 9:42AM $0.330 $0.031 fallen by 90.61%
$9 Trading Halt 11 Sep 2023 9:37AM $0.330 $0.031 fallen by 90.61%
$9 Appendix 4G 29 Aug 2023 5:48PM $0.285 $0.031 fallen by 89.12%
$9 Corporate Governance Statement 29 Aug 2023 5:46PM $0.285 $0.031 fallen by 89.12%
$9 Appendix 4E & Annual Report FY23 29 Aug 2023 5:45PM $0.285 $0.031 fallen by 89.12%
$9 Response to ASX Price and Volume Query 28 Aug 2023 1:26PM $0.335 $0.031 fallen by 90.75%
$9 Firebrick Phase 3 Trial Closes with 500 Subjects 9 Aug 2023 9:04AM $0.180 $0.031 fallen by 82.78%
$9 Firebrick Covid-19 Trial Achieves Primary Endpoint 7 Aug 2023 8:16AM $0.185 $0.031 fallen by 83.24%
$9 Update on Nasodine Phase 2 Study 1 Aug 2023 5:39PM $0.180 $0.031 fallen by 82.78%
$9 June 2023 Quarterly Activity Report & Appendix 4C 27 Jul 2023 8:22AM $0.200 $0.031 fallen by 84.50%
$9 Firebrick Update on AAT Process 20 Jul 2023 8:24AM $0.190 $0.031 fallen by 83.68%
$9 Firebrick Update on Phase 2 Trial Results 12 Jul 2023 5:04PM $0.200 $0.031 fallen by 84.50%
$9 Firebrick Update on AAT Schedule 29 Jun 2023 4:23PM $0.150 $0.031 fallen by 79.33%
$9 Cleansing Notice 21 Jun 2023 2:38PM $0.160 $0.031 fallen by 80.63%
$9 Change of Director's Interest Notice - Stephen Goodall 21 Jun 2023 2:36PM $0.160 $0.031 fallen by 80.63%

201 - 225 of 511 results

Page 9 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.